Hepatocellular Carcinoma: ALN-BCAT Treatment

We are evaluating a new treatment called ALN-BCAT for patients with liver cancer. The goal is to see how well it works compared to current options.

>2 yearsSafety phase (I)HepatologyOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Humanitas Mirasole S.p.A.
Operative unit of Oncology and Hematology
Rozzano, Italy
Centro Ricerche Cliniche Di Verona S.r.l.
Oncology Unit
Verona, Italy
Ospedale San Raffaele S.r.l.
U.O. Oncologia Medica unità di Fase I
Vimodrone, Italy
Sponsor: Alnylam Pharmaceuticals Inc.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.